| |
|
|
|
|
|
|
|||
|
Blood, 15 April 2008, Vol. 111, No. 8, pp. 4184-4192. Prepublished online as a Blood First Edition Paper on January 24, 2008; DOI 10.1182/blood-2007-08-108936.
IMMUNOBIOLOGY Novel biphasic role for lymphocytes revealed during resolving inflammation1 Department of Experimental Medicine and Translational Therapeutics, William Harvey Research Institute, London, United Kingdom; 2 Institute of Cancer, Centre for Translational Oncology, London, United Kingdom; 3 Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, United Kingdom; 4 Conway Institute, University College Dublin, Dublin, Ireland; 5 SW Thames Institute for Renal Research, St Helier Hospital, Carshalton, United Kingdom; and 6 Critical Care, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom
Acute inflammation is traditionally described as the influx of polymorphonuclear leukocytes (PMNs) followed by monocyte-derived macrophages, leading to resolution. This is a classic view, and despite subpopulations of lymphocytes possessing innate immune-regulatory properties, seldom is their role in acute inflammation and its resolution discussed. To redress this we show, using lymphocyte-deficient RAG1–/– mice, that peritoneal T/B lymphocytes control PMN trafficking by regulating cytokine synthesis. Once inflammation ensues in normal mice, lymphocytes disappear in response to DP1 receptor activation by prostaglandin D2. However, upon resolution, lymphocytes repopulate the cavity comprising B1, natural killer (NK),
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||